A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides.
Darja BeyerChristian VaccarinXavier DeupiAna Katrina MapanaoSusan CohrsFan Sozzi-GuoPascal V GrundlerNicholas P van der MeulenJinling WangMatthias TanriverJeffrey W BodeRoger SchibliCristina MüllerPublished in: EJNMMI research (2023)
Ga-labeling at high molar activity, which would be essential to obtain images with high signal-to-background contrast to detect (patho)physiological ACE2 expression levels in patients.